Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BME-TARGET: Core Decompression vs i-Factor vs Autologous BMC for Bone Marrow Edema
NCT03112122Phase 4Terminated
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- Mar 2016
- Primary completion
- Dec 2017
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of i-FACTOR, autologous bone marrow cell concentrate in bone marrow edema (BME), sponsored by Istituto Ortopedico Rizzoli. Started Mar 2016; status: terminated.
02
Drugs
i-FACTORautologous bone marrow cell concentrate
03
Conditions
bone marrow edema (BME)
Beyond the preview
Go deeper on NCT03112122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03112122.